Education
About Us
Working with TipRanks
Follow Us
InfuSystem Holdings, Inc. (INFU)
:INFU
INFU Stock Chart & Stats
Day’s Range― - ―
52-Week Range$4.61 - $11.04
Previous CloseN/A
Volume2.40K
Average Volume (3M)282.60K
Market Cap
$216.11M
Enterprise Value$161.13M
Total Cash (Recent Filing)$720.00K
Total Debt (Recent Filing)$30.45M
Price to Earnings (P/E)44.5
Beta1.59
Next Earnings
Nov 11, 2025EPS Estimate
0.08Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.12
Shares Outstanding20,425,964
10 Day Avg. Volume347,370
30 Day Avg. Volume282,600
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market Cap0.75
Enterprise Value/Revenue1.15
Enterprise Value/Gross Profit2.11
Enterprise Value/Ebitda6.77
Forecast
1Y Price Target
$12.83Price Target Upside20.70% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
Bulls Say, Bears Say
Bulls Say
Financial PerformanceThe Company showed notable progress in gross margin improvement of 122 basis points Y/Y and AEBITDA margin improvement of 282 basis points Y/Y.
Operating Cash FlowOperating cash flow was $20.5M in 2024, an 82% increase Y/Y.
Bears Say
EarningsEPS of $0.04 was below our estimate and consensus of $0.08 and $0.09, respectively.
RevenueRevenue came in below our forecast and consensus due to delays in onboarding new wound care initiatives as the Company looks to improve referral processes with newer partners.
InfuSystem Holdings News
INFU FAQ
What was InfuSystem Holdings, Inc.’s price range in the past 12 months?
InfuSystem Holdings, Inc. lowest stock price was $4.61 and its highest was $11.04 in the past 12 months.
What is InfuSystem Holdings, Inc.’s market cap?
InfuSystem Holdings, Inc.’s market cap is $216.11M.
When is InfuSystem Holdings, Inc.’s upcoming earnings report date?
InfuSystem Holdings, Inc.’s upcoming earnings report date is Nov 11, 2025 which is in 66 days.
How were InfuSystem Holdings, Inc.’s earnings last quarter?
InfuSystem Holdings, Inc. released its earnings results on Aug 05, 2025. The company reported $0.12 earnings per share for the quarter, beating the consensus estimate of $0.036 by $0.084.
Is InfuSystem Holdings, Inc. overvalued?
According to Wall Street analysts InfuSystem Holdings, Inc.’s price is currently Undervalued.
Does InfuSystem Holdings, Inc. pay dividends?
InfuSystem Holdings, Inc. does not currently pay dividends.
What is InfuSystem Holdings, Inc.’s EPS estimate?
InfuSystem Holdings, Inc.’s EPS estimate is 0.08.
How many shares outstanding does InfuSystem Holdings, Inc. have?
InfuSystem Holdings, Inc. has 20,425,964 shares outstanding.
What happened to InfuSystem Holdings, Inc.’s price movement after its last earnings report?
InfuSystem Holdings, Inc. reported an EPS of $0.12 in its last earnings report, beating expectations of $0.036. Following the earnings report the stock price went up 3.761%.
Which hedge fund is a major shareholder of InfuSystem Holdings, Inc.?
Currently, no hedge funds are holding shares in INFU
InfuSystem Holdings Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$12.83 (20.70% Upside)
$12.83 (20.70% Upside)
Blogger Sentiment
Bullish
INFU Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 10.0K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▲ 41.2%
Last 30 Days ▲ 124.3%
Last 30 Days ▲ 124.3%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
66.66%
12-Months-Change
Fundamentals
Return on Equity
9.39%
Trailing 12-Months
Asset Growth
-7.07%
Trailing 12-Months
Company Description
InfuSystem Holdings, Inc.
InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Integrated Therapy Services (ITS) and Durable Medical Equipment Services (DME Services). It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. The company also sells, rents, and leases new and pre-owned pole-mounted and ambulatory infusion pumps, and other durable medical equipment; sells treatment-related consumables; and provides biomedical recertification, maintenance, and repair services for oncology practices, as well as other alternate site settings comprising home care and home infusion providers, skilled nursing facilities, pain centers, hospital market, and others. In addition, it offers local and field-based customer support, as well as operates pump service and repair centers. The company was incorporated in 2005 and is headquartered in Rochester Hills, Michigan.
INFU Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call presented a mixed picture with strong financial performance and strategic initiatives leading to improved margins and cash flow. However, challenges in revenue growth outlook and specific business segments like Advanced Wound Care and ChemoMouthpiece tempered the positive aspects.View all INFU earnings summariesINFU Stock 12 Month Forecast
Average Price Target
$12.83
▲(20.70% Upside)
Technical Analysis
Stereotaxis
―
Utah Medical Products
―
Milestone Scientific
―
REPRO-MED Systems
―
Sanara MedTech
―
Ownership Overview
9.82% Insiders
19.15% Mutual Funds
38.40% Other Institutional Investors
26.37% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---